Three different versions of Alexandria Wingate appear in a trio of purple paintings the Baltimorean started while a fine art ...

The clinical hold doesn’t cover its drug’s Investigational New Drug application for autoimmune hepatitis, for which the Phase ...

The FDA has placed Kezar Life Sciences’ lupus trial on hold after the biotech flagged four deaths during the phase 2b study.

Panelists discuss the updated treatment recommendations for lupus nephritis in the Kidney Disease Improving Global Outcomes and European Alliance of Associations for Rheumatology guidelines ...

Panelists discuss the goals of therapy for lupus nephritis (LN), emphasizing the urgency of treatment to prevent renal flares and the consequences of untreated LN, as well as strategies for ...

After collecting a handful of oncology approvals since its first leukemia nod in 2013, Roche’s Biogen-partnered Rituxan successor, Gazyva, is chasing new horizons in active lupus nephritis.

company Monday said an independent data monitoring committee recommended the suspension after a review of data from the Phase 2b Palizade trial of zetomipzomib to treat patients with lupus nephritis.

In lupus nephritis, disease-causing B cells drive persistent inflammation that damages the kidneys. Despite current treatment options, up to a third of people will develop end-stage kidney disease ...

Lupus nephritis (LN) is a serious manifestation ... LN without reliance on chronic high-dose glucocorticoids. It is the only clinical program to include three years of LN treatment and follow ...